Trial intelligence / Profile preview

Growth Hormone and Endothelial Function in Children

NCT00373386Phase 4Completed

Sponsor
The Ohio State University
Start
Jan 2005
Primary completion
Jun 2007
Modality
Hormone, rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 4 trial of somatropin in growth hormone deficiency (GHD), panhypopituitarism, short stature, sponsored by The Ohio State University. Started Jan 2005; status: completed.

02

Drugs

somatropin
03

Conditions

growth hormone deficiency (GHD)panhypopituitarismshort stature

Beyond the preview

Go deeper on NCT00373386.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00373386.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call